Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram website >

May 21, 2020

State cancer plan has robust input and commitment from Vanderbilt-Ingram Cancer Center

More than a dozen representatives of Vanderbilt University Medical Center helped plan and made a commitment to help carry out the strategy for how Tennessee will prevent cancer and minimize its burden on state residents.

By Tom Wilemon
April 23, 2020

Polygenic scores identify those at high cancer risk

A team of Vanderbilt researchers constructed polygenic risk scores (PRS) based on genomic variants associated with eight common cancers and concluded they could potentially be used for personalized risk assessments.

By Tom Wilemon
red and blue boxing gloves
March 5, 2020

One-two punch for cancer

A drug combination effectively killed aggressive blood cancers in cell and animal models; now it’s being tested in patients.

By Sanjay Mishra
February 27, 2020

Breast cancer study may help predict treatment response

Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat.

By Bill Snyder
February 5, 2020

Vanderbilt-Ingram Cancer Center researchers included in ASCO annual report

Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer.

By Tom Wilemon
February 5, 2020

Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform

Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.

By Tom Wilemon
December 13, 2019

The American College of Medical Genetics and Genomics advises evaluating all breast cancer patients to determine the need for genetic testing

According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.
By Tom Wilemon
November 1, 2019

New Physician Spotlight: Cathy Eng

Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, was recruited to VUMC from The University of Texas MD Anderson Cancer Center in Houston.
By VUMC News and Communications
October 24, 2019

Pietenpol, Wilson land Komen cancer research support

Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.
By Tom Wilemon
September 19, 2019

New telehealth initiative aims to enhance cancer care in rural areas

VUMC is leading an effort to improve cancer care in rural areas with a telehealth initiative supported with a $3.3 million grant from the National Cancer Institute.
By Tom Wilemon
August 7, 2019

Colorectal cancer patients warn against dismissing early symptoms

Younger patients say colorectal cancer is a disease that doesn’t follow age guidelines, so pay attention to early symptoms.
By Tom Wilemon
June 13, 2019

Eng named to GI cancer leadership position at VICC

Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, is joining Vanderbilt-Ingram Cancer Center (VICC).
By Tom Wilemon
April 18, 2019

Team explores fungal infection quandary in lung cancer screenings

Serving a region that lies within the tobacco belt, clinicians at Vanderbilt Health face challenges distinguishing lung cancer from histoplasmosis, a fungal infection that creates cancer-mimicking lesions in the lungs.
By Tom Wilemon
1 … 17 18 19 20 21 … 26